Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition) Hitoshi TsudaGeneral Rule Committee of the Japanese Breast Cancer Society Special Article 09 March 2020 Pages: 309 - 321
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition Tatsunori ShimoiShigenori E. NagaiTatsuya Toyama Special Article Open access 02 April 2020 Pages: 322 - 331
The era of meta-analyses-based recommendations: how were the Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer established? Toshimi Takano Special Feature 27 April 2020 Pages: 332 - 333
Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition Tetsuhiro YoshinamiKei KoizumiHiroji Iwata Special Feature 08 January 2020 Pages: 334 - 339
First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis Tatsunori ShimoiYasuaki SagaraHiroji Iwata Special Feature Open access 11 February 2020 Pages: 340 - 346
Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials Minoru MiyashitaMasaya HattoriHiroji Iwata Special Feature 23 January 2020 Pages: 347 - 354
DNA damage repair functions and targeted treatment in breast cancer Chenfeng HeKosuke KawaguchiMasakazu Toi Review Article 02 January 2020 Pages: 355 - 362
BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer Kai LiWen-ting PanJing-wei Zhang Original Article 14 November 2019 Pages: 363 - 371
18F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer Honglian LiuHao SunYang He Original Article 28 November 2019 Pages: 372 - 380
Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups Brigid K. KilleleaJeph HerrinCary P. Gross Original Article 02 December 2019 Pages: 381 - 388
Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study Hidetoshi KawaguchiNorikazu MasudaShinji Ohno Original Article Open access 06 December 2019 Pages: 389 - 398
First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis Weiting LiaoJiaxing HuangQiu Li Original Article 18 December 2019 Pages: 399 - 404
High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up Satoko OkamotoShu-Tian ChenDebra M. Ikeda Original Article 14 December 2019 Pages: 405 - 414
Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells Emi KishinoRyohei OgataJunichi Kurebayashi Original Article 10 December 2019 Pages: 415 - 425
Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers L. S. E. van EgdomM. A. de KockL. B. Koppert Original Article Open access 12 December 2019 Pages: 426 - 434
Higher reconstruction failure and less patient-reported satisfaction after post mastectomy radiotherapy with immediate implant-based breast reconstruction compared to immediate autologous breast reconstruction F. C. J. ReindersD. A. Young-AfatW. Maarse Original Article 19 December 2019 Pages: 435 - 444
Growth pattern can be used as a new characteristic to predict malignancy in breast cancer Bin WangLizhe ZhuKe Wang Original Article Open access 03 January 2020 Pages: 445 - 455
Conversion rate from mastectomy to breast conservation after neoadjuvant dual target therapy for HER2-positive breast cancer in the Asian population Yuk-Kwan ChangMichael CoAva Kwong Original Article 08 January 2020 Pages: 456 - 463
Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing Ling ZhangXiaojuan ZhangJing Liu Original Article 09 January 2020 Pages: 464 - 476
Comorbidity and polypharmacy in patients with breast cancer Ulaş Serkan TopaloğluErsin Özaslan Original Article 02 January 2020 Pages: 477 - 482
Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer Tolga AcunKerem Mert Senses Original Article 04 January 2020 Pages: 483 - 489
Microsatellite instability in Japanese female patients with triple-negative breast cancer Kanako KurataMakoto KuboMasafumi Nakamura Original Article Open access 06 January 2020 Pages: 490 - 498
Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient Yoko OhishiAki MitsudaToshiharu Minabe Case Report Open access 24 February 2020 Pages: 499 - 504
Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer Stéphanie BlockhuysDonita C. BradyPernilla Wittung-Stafshede Rapid Communication Open access 02 January 2020 Pages: 505 - 509